WallStreetZenWallStreetZen

NASDAQ: FBRX
Forte Biosciences Inc Earnings & Revenue

FBRX past revenue growth

How has FBRX's revenue growth performed historically?
Company
N/A
Industry
81.78%
Market
19.94%
FBRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FBRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

FBRX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$32.1M
Current Profit Margin
0%

FBRX Return on Equity

Current Company
-99.4%
Current Industry
16.8%
Current Market
28.2%
FBRX's Return on Equity (-99.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when FBRX announces earnings.

FBRX Return on Assets

Current Company
-85.7%
Current Industry
3.2%
FBRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FBRX Return on Capital Employed

Current Company
-112.06%
Current Industry
-42.4%
FBRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FBRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FBRX$0.00-$32.13M-$32.14M-100.00%N/A
IBIO$50.00k-$21.76M-$23.16M-47.99%N/A
NRXS$2.30M-$14.15M-$14.57M-15.37%N/A
SYBX$3.21M-$68.01M-$73.22M+5.06%N/A
LUMO$1.53M-$37.12M-$37.13M-9.94%N/A

Forte Biosciences Earnings & Revenue FAQ

What were FBRX's earnings last quarter?

On Invalid Date, Forte Biosciences (NASDAQ: FBRX) reported Q1 2024 earnings per share (EPS) of -$0.16, up 50% year over year. Total Forte Biosciences earnings for the quarter were -$7.42 million. In the same quarter last year, Forte Biosciences's earnings per share (EPS) was -$0.32.

If you're new to stock investing, here's how to buy Forte Biosciences stock.

What was FBRX's earnings growth in the past year?

As of Q2 2024, Forte Biosciences's earnings has grown year over year. Forte Biosciences's earnings in the past year totalled -$32.14 million.

What was FBRX's revenue last quarter?

On Invalid Date, Forte Biosciences (NASDAQ: FBRX) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Forte Biosciences's revenue was $0.00.

What was FBRX's revenue growth in the past year?

As of Q2 2024, Forte Biosciences's revenue has grown null year over year. Forte Biosciences's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.